Harvard Management as of Dec. 31, 2022
Portfolio Holdings for Harvard Management
Harvard Management holds 46 positions in its portfolio as reported in the December 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Alphabet Cap Stk Cl A (GOOGL) | 26.4 | $213M | 2.4M | 88.23 | |
Scientific Games (LNW) | 19.5 | $157M | 2.7M | 58.60 | |
Meta Platforms Cl A (META) | 16.9 | $137M | 1.1M | 120.34 | |
Grab Holdings Class A Ord (GRAB) | 5.2 | $42M | 13M | 3.22 | |
Abcellera Biologics (ABCL) | 5.2 | $42M | 4.1M | 10.13 | |
Purecycle Technologies *w Exp 03/17/202 (PCTTW) | 2.1 | $17M | 714k | 23.64 | |
Revolution Medicines (RVMD) | 2.0 | $16M | 670k | 23.82 | |
Recursion Pharmaceuticals In Cl A (RXRX) | 1.4 | $12M | 1.5M | 7.71 | |
ASML Holding N V N Y Registry Shs (ASML) | 1.4 | $11M | 20k | 546.40 | |
Pliant Therapeutics (PLRX) | 1.3 | $11M | 562k | 19.33 | |
Meli Kaszek Pioneer Corp Class A Ord | 1.2 | $10M | 1.0M | 9.97 | |
NVIDIA Corporation (NVDA) | 1.2 | $9.7M | 66k | 146.14 | |
Qorvo (QRVO) | 1.2 | $9.5M | 105k | 90.64 | |
Eqrx | 1.2 | $9.5M | 3.9M | 2.46 | |
Analog Devices (ADI) | 1.1 | $9.0M | 55k | 164.03 | |
Applied Materials (AMAT) | 1.1 | $8.6M | 88k | 97.38 | |
Relay Therapeutics (RLAY) | 1.0 | $8.1M | 541k | 14.94 | |
Lam Research Corporation (LRCX) | 1.0 | $8.0M | 19k | 420.30 | |
Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 1.0 | $8.0M | 107k | 74.49 | |
Advanced Micro Devices (AMD) | 0.9 | $7.3M | 112k | 64.77 | |
10X Genomics Cl A Com (TXG) | 0.8 | $6.8M | 186k | 36.44 | |
Intel Corporation (INTC) | 0.7 | $5.5M | 208k | 26.43 | |
Micron Technology (MU) | 0.7 | $5.4M | 108k | 49.98 | |
Tango Therapeutics (TNGX) | 0.6 | $5.1M | 708k | 7.25 | |
Rocket Lab Usa (RKLB) | 0.5 | $3.8M | 1.0M | 3.77 | |
Vigil Neuroscience (VIGL) | 0.4 | $3.6M | 290k | 12.50 | |
Nurix Therapeutics (NRIX) | 0.4 | $3.5M | 315k | 10.98 | |
Kinnate Biopharma | 0.4 | $3.0M | 498k | 6.10 | |
Fulcrum Therapeutics (FULC) | 0.4 | $3.0M | 411k | 7.28 | |
Confluent Class A Com (CFLT) | 0.4 | $2.9M | 130k | 22.24 | |
Purecycle Technologies (PCT) | 0.3 | $2.1M | 2.5M | 0.82 | |
Generation Bio (GBIO) | 0.2 | $2.0M | 510k | 3.93 | |
Pacific Biosciences of California (PACB) | 0.2 | $1.9M | 229k | 8.18 | |
Nauticus Robotics (KITT) | 0.2 | $1.9M | 500k | 3.74 | |
Praxis Precision Medicines I | 0.2 | $1.9M | 779k | 2.38 | |
Sana Biotechnology (SANA) | 0.2 | $1.9M | 469k | 3.95 | |
Affirm Hldgs Com Cl A (AFRM) | 0.2 | $1.7M | 174k | 9.67 | |
Tenaya Therapeutics (TNYA) | 0.2 | $1.4M | 673k | 2.01 | |
Dyne Therapeutics (DYN) | 0.2 | $1.2M | 107k | 11.59 | |
Xilio Therapeutics (XLO) | 0.1 | $1.1M | 416k | 2.69 | |
Seres Therapeutics (MCRB) | 0.1 | $738k | 132k | 5.60 | |
Pardes Biosciences | 0.1 | $676k | 400k | 1.69 | |
Decibel Therapeutics | 0.1 | $674k | 329k | 2.05 | |
Disc Medicine (IRON) | 0.1 | $497k | 25k | 19.89 | |
Surrozen | 0.1 | $481k | 827k | 0.58 | |
Magenta Therapeutics | 0.0 | $131k | 333k | 0.40 |